Status: current, Defined. Date: 28-Feb 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3612281000168114 | Bicalutamide (SCP) (bicalutamide 50 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3612291000168112 | Bicalutamide (SCP) 50 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bicalutamide (SCP) 50 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Bicalutamide (SCP) 50 mg tablet | Is a | bicalutamide 50 mg tablet | true | Inferred relationship | Some | ||
| Bicalutamide (SCP) 50 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bicalutamide (SCP) 50 mg tablet | Is a | Bicalutamide (SCP) | true | Inferred relationship | Some | ||
| Bicalutamide (SCP) 50 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Bicalutamide (SCP) 50 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 324892637 | |
| Bicalutamide (SCP) 50 mg tablet | has Australian BoSS | bicalutamide | true | Inferred relationship | Some | 324892636 | |
| Bicalutamide (SCP) 50 mg tablet | has intended active ingredient | bicalutamide | true | Inferred relationship | Some | 324892636 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bicalutamide (SCP) 50 mg tablet, 28 | has TPUU | True | Bicalutamide (SCP) 50 mg tablet | Inferred relationship | Some | 1 |
| Bicalutamide (SCP) 50 mg tablet, 28, blister pack | has TPUU | True | Bicalutamide (SCP) 50 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR